What is CJC-1295?
CJC 1295 is a synthetic growth hormone releasing (GHRH) peptide that is comprised of 30 amino acids. It is recognized as the most effective GHRH used for growth hormone optimization and can be combined (stacked) with other peptides, such as Ipamorelin, for a powerful synergistic effect, and is often included in a HRT program to manage aging, and a TRT program for enhanced performance. CJC 1295 has demonstrated the ability to increase fat loss and bolster muscle mass while enabling the body to more efficiently synthesize protein. In addition to steadily maximizing GH production, CJC 1295 also increases the secretion of insulin-like growth factor 1 (IGF-1). Primarily secreted by the liver, IGF-1 is an anabolic hormone that helps promote human growth throughout the entire body, particularly skeletal muscle. IGF-1 also aids in bone density and kidney filtration. One of the key advantages of CJC 1295 is that it does not increase the production of potentially contraindicated hormones such as prolactin. CJC 1295 is usually administered via subcutaneous injection.